Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Marfan Syndrome

valsartan has been researched along with Marfan Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Angeletti, S; Anguissola, GB; Bono, MC; Ciccozzi, M; Costantino, S; Locorriere, L; Pantano, AL; Spoto, S; Terracciani, F; Valeriani, E1
Bernatchez, P; Esfandiarei, M; Milad, N; Seidman, MA; Tehrani, AY; White, Z1
Mir, TS; Mueller, GC; Stark, V; Steiner, K; Stierle, L; von Kodolitsch, Y; Weil, J1

Other Studies

3 other study(ies) available for valsartan and Marfan Syndrome

ArticleYear
Use of sacubitril/valsartan in Marfan syndrome-related cardiomyopathy: The first case report.
    Medicine, 2019, Volume: 98, Issue:47

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Male; Marfan Syndrome; Tetrazoles; Treatment Outcome; Valsartan; Young Adult

2019
Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan.
    Physiological reports, 2021, Volume: 9, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Losartan; Marfan Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organ Culture Techniques; Valsartan

2021
Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
    Heart (British Cardiac Society), 2014, Volume: 100, Issue:3

    Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Age Factors; Angiotensin II Type 1 Receptor Blockers; Aortic Diseases; Child; Child, Preschool; Dilatation, Pathologic; Female; Humans; Male; Marfan Syndrome; Metoprolol; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan

2014